Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

LXEO - Lexeo Therapeutics Inc.

IEX Last Trade
11.5
-0.120   -1.043%

Share volume: 142,018
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$11.62
-0.12
-1.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-4.48%
1 Month
-9.51%
3 Months
-28.29%
6 Months
-23.83%
1 Year
14.53%
2 Year
14.53%
Key data
Stock price
$11.50
P/E Ratio 
-6.42
DAY RANGE
N/A - N/A
EPS 
-$2.28
52 WEEK RANGE
$9.00 - $22.33
52 WEEK CHANGE
$0.15
MARKET CAP 
380.532 M
YIELD 
N/A
SHARES OUTSTANDING 
33.061 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/14/2024
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$164,710
AVERAGE 30 VOLUME 
$202,804
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news